Search

everythinglearnresearchcommunity

for

Search:↓

The technique effectively repairs skin after tumor removal, maintaining appearance and function without complications.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Some drugs used to treat immune conditions may cause different types of hair loss.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Minor injuries to hair follicles can stimulate hair growth in mice by increasing a specific protein.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

B cells can both help and hinder the body's defense against melanoma.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Some drugs for inflammation may cause psoriasis-like hair loss.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Anti-TNF therapy can cause hair loss and skin issues.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

An alpaca acted like a male and couldn't have babies because of a benign tumor in its ovary that caused high testosterone levels.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

An 80-year-old woman's severe hair loss was caused by a hormone-secreting ovarian tumor.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.